Gates, Bezos-backed Blood Testing Firm Nears $1 Billion Funding

GRAIL, a startup that is backed by both Bill Gates and Jeff Bezos, and which is developing blood testing technology for early stage cancer detection, is expecting to close a $1 billion, Series B funding, according to its founding investor

The story you have requested is only available to paid members of the Northwest Innovation web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.